Recce Pharmaceuticals Ltd Stock Forecast

Recce Pharmaceuticals Ltd stock downgraded to Hold/Accumulate
(Updated on May 17, 2024)

RCE.AX Signals & Forecast

The Recce Pharmaceuticals Ltd stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $0.625. On a fall, the stock will find some support from the long-term average at approximately $0.566. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, April 24, 2024, and so far it has fallen -13.14%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Recce Pharmaceuticals Ltd gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Recce Pharmaceuticals Ltd stock

On the downside, the stock finds support just below today's level from accumulated volume at $0.530 and $0.455. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Recce Pharmaceuticals Ltd finds support just below today's level at $0.530. If this is broken, then the next support from accumulated volume will be at $0.455 and $0.450.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0300 between high and low, or 5.04%. For the last week, the stock has had daily average volatility of 4.45%.

Our recommended stop-loss: $0.569 (-4.29%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 16 days ago.)

Trading Expectations (RCE.AX) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Recce Pharmaceuticals Ltd to open at $0.605, and during the day (based on 14 day Average True Range), to move between $0.568 and $0.622, which gives a possible trading interval of +/-$0.0272 (+/-4.57%) up or down from last closing price. If Recce Pharmaceuticals Ltd takes out the full calculated possible swing range there will be an estimated 9.15% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.650 (9.24%) than the support at $0.530 (10.92%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Recce Pharmaceuticals Ltd stock A Buy?

Recce Pharmaceuticals Ltd holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.718 Hold/Accumulate Downgraded

Predicted Opening Price for Recce Pharmaceuticals Ltd of Monday, May 20, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.